News | February 16, 2012

Children's Hospital of Michigan Cardiovascular Surgeon Testifies on Berlin Heart

February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD) as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, M.D., the hospital’s chief of cardiovascular surgery. He provided testimony about the device at a recent public hearing. After reviewing the clinical trial data and hearing testimony from Walters and others, the device was approved.

The Berlin Heart is the first VAD made specifically for pediatric patients. VADs are common in adults, but, until recently, were not manufactured in pediatric sizes.

Ventricular assist devices are used when a patient needs a heart transplant, but can't wait for a donor heart to become available. The Berlin Heart assists the failing heart until an appropriate donor heart can be found.

"A few times a year, we are faced with a situation where a child simply can't wait for a heart transplant," Walters said. "In these cases, the Berlin Heart works very well and the children generally stabilize and start to thrive and improve while they wait for a donor heart."

Before the device was approved by the Walters and his colleagues used the Berlin Heart under the FDA's "compassionate use" regulations.

Since 2005, Walters and his colleagues have inserted 14 Berlin Hearts. Of the 14 patients, 10 survived to cardiac transplantation and nine are thriving today - a result directly attributable to the efficacy of the Berlin Heart. The nine survivors ranged in age from six months to 13 years.

Before availability of the Berlin Heart, Walters and his colleagues occasionally adapted an adult ventricular assist device for use in a child, but the results were not optimal and some patients were too small for a modified adult device.

"The Berlin Heart stands alone in filling a tremendous void in the field of pediatric cardiac failure. I can honestly say that of our nine survivors, eight were too small to have possibly accommodated any of the available adult ventricular assist devices. For these patients the Berlin Heart was truly the key to their survival," adds Walters.

The pediatric heart transplant program at the DMC Children's Hospital of Michigan is the largest in the state of Michigan and one of the largest in the Midwest.

For more information: www.childrensdmc.org

Related Content

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Sponsored Content | Videos | Cardiovascular Ultrasound| August 28, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
CMS Awards New Technology Add-on Payment for Perceval Sutureless Aortic Heart Valve
News | Heart Valve Technology| August 22, 2017
August 22, 2017 — LivaNova PLC announced its Perceval ...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Overlay Init